Challenges of non-COVID-19 patients with chronic illness during the pandemic.

IF 0.8 Q4 PHARMACOLOGY & PHARMACY

Journal of Research in Pharmacy Practice Pub Date : 2020-10-08 eCollection Date: 2020-07-01 DOI:10.4103/jrpp.JRPP_20_64

Debi Ann Abraham, Thangavel Mahalingam Vijayakumar, Muhasaparur Ganesan Rajanandh

引用次数: 14

Abstract

Challenges faced by non-COVID-19 patients with chronic illness are limitless during the lockdown period. These patients are mostly immunocompromised and vulnerable to infection. The worst affected would be chronic disease patients with lower household income. Patients' fear of approaching medical facilities and also travel restrictions limit the patients to reach the healthcare team, and either of this leads to poor health outcome. Frequent communication with chronic disease patients by healthcare professionals is a key to encourage the patients to be adherent to the medications and manage their disease conditions.

查看原文本刊更多论文

大流行期间非covid -19慢性病患者面临的挑战。

在封锁期间，非covid -19慢性病患者面临的挑战是无限的。这些患者大多免疫功能低下，易受感染。受影响最严重的是家庭收入较低的慢性病患者。患者对接近医疗设施的恐惧以及旅行限制限制了患者接触医疗团队，这两种情况都会导致健康状况不佳。医护人员与慢性病患者的频繁沟通是鼓励患者坚持服药和控制病情的关键。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Research in Pharmacy Practice PHARMACOLOGY & PHARMACY-

自引率

0.00%

发文量

审稿时长

21 weeks

期刊介绍： The main focus of the journal will be on evidence-based drug-related medical researches (with clinical pharmacists’ intervention or documentation), particularly in the Eastern Mediterranean region. However, a wide range of closely related issues will be also covered. These will include clinical studies in the field of pharmaceutical care, reporting adverse drug reactions and human medical toxicology, pharmaco-epidemiology and toxico-epidemiology (poisoning epidemiology), social aspects of pharmacy practice, pharmacy education and economic evaluations of treatment protocols (e.g. cost-effectiveness studies). Local reports of medication utilization studies at hospital or pharmacy levels will only be considered for peer-review process only if they have a new and useful message for the international pharmacy practice professionals and readers.